• Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Development Partners
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
  • Contact
  • en
  • Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Development Partners
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
  • Contact
  • en

News

Home / News /
  0
By Erika Medin
In News
Posted 22 December 2020

BioStock article: Aptahem’s wish list for next year’s Christmas

BioStock published an article on 22 December 2020 about Aptahem, which can be read in full below. Aptahem, which is developing an emergency medicine for the treatment of sepsis, carried out an [...]

READ MORE
  0
By Erika Medin
In News
Posted 8 December 2020

BioStock article: Aptahem looks ahead with optimism

BioStock published an article on 8 December 2020 about Aptahem, which can be read in full below. Aptahem, whose primary drug candidate Apta-1 is being developed as an emergency treatment [...]

READ MORE
  0
By Erika Medin
In News
Posted 26 November 2020

BioStock article: Aptahem approaching milestone via oversubscribed rights issue

BioStock published an article on 26 November 2020 about Aptahem, which can be read in full below. Biotechnology company Aptahem, that develops its drug candidate Apta-1 for the treatment of [...]

READ MORE
  0
By Erika Medin
In News
Posted 21 October 2020

Aptahem enters collaboration agreement with Granzer Regulatory Consulting and Services to prepare for clinical stage

Aptahem AB (publ), announce today that the company enters a collaboration agreement with the German company Granzer Regulatory Consulting and Services to prepare for applications to the European [...]

READ MORE
  0
By Erika Medin
In News
Posted 16 October 2020

BioStock article: Aptahem’s founder is back – now as Chairman of the Board

BioStock published an article on 15 October 2020 about Aptahem, which can be read in full below. On September 25, Bert Junno was elected Chairman of the Board of the biotech company Aptahem. As a [...]

READ MORE
  0
By Dennis Andersson
In News
Posted 17 September 2020

The largest shareholder of Aptahem suggests Dr Bert Junno as the new Chairman of the Board

Aptahem AB (publ), announce today that the company’s largest shareholder, Ivar Nordqvist, suggests Dr Bert Junno to be elected new Chairman of the Board at the coming Extraordinary General [...]

READ MORE
  0
By Erika Medin
In News
Posted 3 September 2020

The Chairman of the Board of Directors at Aptahem has announced his resignation

Aptahem AB (publ), announce today that the Chairman of the Board of Directors, Kjell G Stenberg, has requested his own resignation from the Board. Due to this, the Board of Directors will call [...]

READ MORE
  0
By Erika Medin
In News
Posted 10 August 2020

The first larger scale production campaign of Aptahem’s lead candidate Apta-1 is now ready to start

Aptahem AB, a leading developer of aptamer-based drugs, announced today that the company is now starting large-scale manufacturing after LGC Bioresearch Technologies Inc. (LGC) completed the [...]

READ MORE
  0
By Erika Medin
In News
Posted 10 July 2020

BioStock article: Aptahem comments on the new Covid-19 project

BioStock published an article on 10 July 2020 about Aptahem, which can be read in full below. Last night, Malmö-based Aptahem announced that they have entered a preclinical collaboration with the [...]

READ MORE
  0
By Erika Medin
In News
Posted 9 July 2020

Aptahem enters a collaboration with University Health Network in Canada to test Apta-1 in a coronavirus model

Aptahem (publ) today announced the beginning of a collaboration with the University Health Network, a research hospital affiliated with University of Toronto in Canada. The collaboration aims to [...]

READ MORE
1 2 3 4 5 6
page 1 of 6
Contact



Norra Vallgatan 58, 4 TR
211 22 Malmö
Sweden
E-mail: info@aptahem.com

Aptahem is supporting Sepsisfonden & Global Sepsis Alliance
To all salesmen:

We kindly decline all direct contact with salesmen of different types of products and services.

Copyright All Rights Reserved © 2016

Start typing and press Enter to search